| Crosstalk in Met receptor oncogenesis AZ Lai, JV Abella, M Park Trends in cell biology 19 (10), 542-551, 2009 | 250 | 2009 |
| RET ligand-induced internalization and its consequences for downstream signaling DS Richardson, AZ Lai, LM Mulligan Oncogene 25 (22), 3206-3211, 2006 | 96 | 2006 |
| Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer AZ Lai, S Cory, H Zhao, M Gigoux, A Monast, MC Guiot, S Huang, ... Science signaling 7 (322), ra38-ra38, 2014 | 48 | 2014 |
| RET signaling in endocrine tumors: delving deeper into molecular mechanisms AZ Lai, TS Gujral, LM Mulligan Endocrine Pathology 18, 57-67, 2007 | 43 | 2007 |
| Mutation of MET Y1230 as an acquired mechanism of crizotinib resistance in NSCLC with MET exon 14 skipping AB Schrock, A Lai, SM Ali, VA Miller, LE Raez Journal of Thoracic Oncology 12 (7), e89-e90, 2017 | 38 | 2017 |
| Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer AZ Lai, M Durrant, D Zuo, CDH Ratcliffe, M Park Journal of Biological Chemistry 287 (11), 8048-8059, 2012 | 37 | 2012 |
| Protein-tyrosine phosphatase 1B modulates early endosome fusion and trafficking of Met and epidermal growth factor receptors V Sangwan, J Abella, A Lai, N Bertos, M Stuible, ML Tremblay, M Park Journal of Biological Chemistry 286 (52), 45000-45013, 2011 | 36 | 2011 |
| Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA AZ Lai, AB Schrock, RL Erlich, JS Ross, VA Miller, E Yakirevich, SM Ali, ... The Oncologist 22 (7), 774-779, 2017 | 21 | 2017 |
| Protein tyrosine phosphatase PTP1B modulates early endosome fusion and trafficking of Met and EGF receptor tyrosine kinases V Sangwan, J Abella, A Lai, N Bertos, M Stuible, ML Tremblay, M Park J. Biol. Chem 286, 45000-45013, 2011 | 5 | 2011 |
| Continued Response to One Dose of Nivolumab Complicated by Myasthenic Crisis and Myositis AB Schrock, A Lai, SM Ali, VA Miller, LE Raez Oncol 11, 1242-1245, 2016 | | 2016 |
| Abstract LB-77: The Met receptor tyrosine kinase drives signaling through EGFR and ErbB3 in Met-amplified non-small-cell lung cancer YE Stern, AZ Lai, M Park Cancer Research 74 (19_Supplement), LB-77-LB-77, 2014 | | 2014 |
| Characterization of oncogenic signalling and mechanisms of resistance to inhibitors of Met in Gastric Cancer A Lai McGill University, 2014 | | 2014 |
| Dynamic reprogramming of signaling following Met inhibition reveals pathways for cell proliferation and negative feedback in gastric cancer. A Lai, S Cory, H Zhao, B Sehat, A Tofigh, MC Guiot, C Thompson, ES Bell, ... MOLECULAR CANCER THERAPEUTICS 12 (11), 2013 | | 2013 |
| Abstract B69: Dynamic reprogramming of signaling following Met inhibition reveals pathways for cell proliferation and negative feedback in gastric cancer. A Lai, S Cory, H Zhao, B Sehat, A Tofigh, MC Guiot, C Thompson, ES Bell, ... Molecular Cancer Therapeutics 12 (11_Supplement), B69-B69, 2013 | | 2013 |
| Establishing mechanisms of acquired resistance to Met inhibitor in Met-addicted gastric cancer cell lines. AZ Lai, C Thompson, S Cory, H Zhao, N Chughtai, M Hallett, M Park Cancer Research 73 (8_Supplement), 967-967, 2013 | | 2013 |
| Abstract B45: Met-Dependent Positive and Negative Signaling Cascades in Gastric Cancer Cells AZ Lai, S Cory, H Zhao, ES Bell, M Hallett, M Park Clinical Cancer Research 18 (10_Supplement), B45-B45, 2012 | | 2012 |
| Met receptor tyrosine kinase cross-talk in tumorigenesis A Lai, M Park Cancer Research 71 (8_Supplement), 4688-4688, 2011 | | 2011 |
Morag ParkProfessor of Oncology and Biochemistry, McGill University, Director Goodman Cancer Research CentreVerified email at mcgill.ca
